Others

Granules USA, the wholly owned subsidiary of Granules India Ltd., entered into an agreement with Par Pharmaceutical Inc. to market generic version of omeprazole and sodium bicarbonate

| Updated on January 21, 2016 Published on January 21, 2016

Granules India Ltd has informed BSE regarding a Press Release dated January 21, 2016, titled "Granules USA, the wholly owned subsidiary of Granules India Ltd., entered into an agreement with Par Pharmaceutical Inc. to market generic version of omeprazole and sodium bicarbonate".

Pdf Link: >Granules USA, the wholly owned subsidiary of Granules India Ltd., entered into an agreement with Par Pharmaceutical Inc. to market generic version of omeprazole and sodium bicarbonate

Source : BSE - >www.bseindia.com

Published on January 21, 2016
This article is closed for comments.
Please Email the Editor